Overview
Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis
Status:
Unknown status
Unknown status
Trial end date:
2016-06-01
2016-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the treatment of demodicidosis (including papulopustular rosacea)Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Rabin Medical CenterTreatments:
Ivermectin
Criteria
Inclusion Criteria:- subjects with clinical and laboratory diagnosis of demodicidosis with symmetrical
facial eruption who are willing to comply with study requirements
Exclusion Criteria:
- known hypersensitivity to ivermectin.
- pregnancy
- immunodeficiency such as HIV or immunosuppressive therapy
- concomitant use of systemic antibiotics or steroids